Shire Pharmaceuticals Group plc metabolic news

SEC filed a civil fraud action in the U.S. District Court for the District of Massachusetts against Richard Selden, former CEO of SHP's Transkaryotic Therapies Inc. (Cambridge, Mass.) subsidiary. The ...